Valhi logo
Valhi VHI
$ 18.66 4.66%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Valhi Balance Sheet 2025-2008 | VHI

Brief overview of Valhi's assets and capital

The balance sheet is assessed across five available annual reports spanning 2015 to 2019.

Across five periods, assets reached $2.8 billion versus $2.5 billion initially. Growth of +10.1% reflects gradual development.

Growth in the asset base was not matched by liabilities: +10.1% versus -9.8%. The balance sheet moved in a more conservative direction.

Equity funds just 22.9% of assets versus 10.6% previously. The balance sheet is sensitive to weaker results.

The net-debt-to-equity ratio is 0.42x. Balance sheet leverage is low on this measure.

Cash accounts for 18.7% of assets versus 8% initially. The change indicates the degree of financial flexibility.

Retained earnings stand at $239.4 million; the five-period change was +253.9%. This reflects accumulated business performance.

Conclusion

Taken together, the figures indicate acceptable resilience for Valhi. The next assessment depends on debt and equity trends.

Annual Balance Sheet Valhi

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Net Debt

381 M 140 M 143 M 83 M -44.8 M 274 M 270 M 301 M 607 M 805 M 758 M 678 M 610 M 543 M 640 M 598 M - -

Long Term Debt

591 M 484 M 546 M 558 M 650 M 786 M 789 M 798 M 1.04 B 957 M 951 M 925 M 742 M 880 M 717 M 923 M - -

Long Term Debt Current

4.2 M 3.5 M 3.9 M 3.8 M 3.7 M 6.7 M 6.2 M - - - - - - - - - - -

Total Non Current Liabilities

819 M 777 M 954 M 1.04 B 1.38 B 1.56 B 1.49 B 1.37 B 1.81 B 1.7 B 1.72 B 1.82 B 1.58 B 1.68 B 1.43 B 1.59 B - -

Total Current Liabilities

449 M 644 M 507 M 493 M 464 M 318 M 322 M 351 M 331 M 294 M 287 M 331 M 395 M 398 M 416 M 306 M - -

Total Liabilities

- - - - - - 1.81 B 1.72 B 2.14 B 2 B 2.01 B 2.15 B 1.97 B 2.08 B 1.84 B - - -

Deferred Revenue

25.9 M 28.2 M 88.8 M 111 M 126 M 20.1 M 10.3 M 28.3 M 28.3 M 32 M 21.8 M 19.8 M 36.9 M 5.4 M 3.5 M - - -

Retained Earnings

508 M 575 M 476 M 482 M 401 M 283 M 239 M 220 M -17.9 M -198 M -156 M 4.9 M -39.6 M 75.4 M -19.4 M -183 M - -

Total Assets

2.63 B 2.8 B 2.74 B 2.84 B 3.01 B 2.89 B 2.79 B 2.71 B 2.91 B 2.44 B 2.54 B 2.97 B 2.97 B 3.17 B 2.84 B 2.71 B - -

Cash and Cash Equivalents

214 M 348 M 407 M 478 M 698 M 519 M 524 M 500 M 436 M 160 M 202 M 256 M 143 M 367 M 96.4 M 325 M 68.7 M 37 M

Book Value

2.63 B 2.8 B 2.74 B 2.84 B 3.01 B 2.89 B 980 M 989 M 767 M 444 M 527 M 814 M 993 M 1.09 B 993 M 2.71 B - -

Total Shareholders Equity

1.02 B 1.04 B 950 M 959 M 1.16 B 1.01 B 640 M 635 M 424 M 201 M 269 M 478 M 601 M 734 M 657 M 542 M 498 M 542 M

All numbers in USD currency

Quarterly Balance Sheet Valhi

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

587 M 624 M 662 M 545 M 526 M 527 M 497 M 511 M 532 M 550 M 560 M 558 M 538 M - 638 M 650 M 693 M 743 M 763 M 786 M 786 M 786 M 786 M 789 M 789 M 789 M 789 M 798 M 798 M 798 M 798 M 1.04 B 1.04 B 1.04 B 1.04 B 889 M 957 M 957 M 957 M 951 M 951 M 951 M 951 M 920 M 925 M 925 M 925 M 742 M 742 M 742 M 742 M 880 M 803 M 864 M 880 M 736 M 717 M 887 M 717 M

Total Non Current Liabilities

814 M 853 M 946 M 850 M 815 M 917 M 868 M 924 M 938 M 980 M 1.03 B 1.04 B 1.13 B - 1.35 B 1.38 B 1.47 B 1.5 B 1.53 B 1.56 B 1.56 B 1.56 B 1.56 B 1.49 B 1.49 B 1.49 B 1.49 B 1.37 B 1.37 B 1.37 B 1.37 B 1.81 B 1.81 B 1.81 B 1.81 B 1.7 B 1.7 B 1.7 B 1.7 B 1.72 B 1.72 B 1.72 B 1.72 B 1.8 B 1.82 B 1.82 B 1.82 B 1.58 B 1.58 B 1.58 B 1.58 B 1.68 B 1.68 B 1.68 B 1.68 B 1.43 B 1.43 B 1.43 B 1.43 B

Deferred Revenue

26.3 M 27.1 M 25.9 M 27.4 M 32.3 M 50.8 M 50.4 M 69.1 M 101 M 83.4 M 100 M 111 M 105 M - 120 M 126 M 35.3 M 15.5 M 18.2 M 20.1 M 20.1 M 20.1 M 20.1 M 10.3 M 10.3 M 10.3 M 10.3 M 28.3 M 28.3 M 28.3 M 28.3 M 28.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

528 M 508 M 564 M 588 M 589 M 554 M 499 M 467 M 460 M 468 M 475 M 482 M 494 M - 444 M 401 M 351 M 315 M 296 M 283 M 283 M 283 M 283 M 239 M 239 M 239 M 239 M 220 M 220 M 220 M 220 M -17.9 M -17.9 M -17.9 M -17.9 M -198 M -198 M -198 M -198 M -156 M -156 M -156 M -156 M 4.9 M 4.9 M 4.9 M 4.9 M -39.6 M -39.6 M -39.6 M -39.6 M 75.4 M 75.4 M 75.4 M 75.4 M -19.4 M -19.4 M -19.4 M -19.4 M

Total Assets

2.57 B 2.61 B 2.72 B 2.76 B 2.76 B 2.79 B 2.53 B 2.56 B 2.61 B 2.65 B 2.72 B 2.84 B 2.84 B - 3.02 B 3.01 B 2.88 B 2.81 B 2.87 B 2.89 B 2.89 B 2.89 B 2.89 B 2.79 B 2.79 B 2.79 B 2.79 B 2.71 B 2.71 B 2.71 B 2.71 B 2.91 B 2.91 B 2.91 B 2.91 B 2.44 B 2.44 B 2.44 B 2.44 B 2.54 B 2.54 B 2.54 B 2.54 B 2.95 B 2.97 B 2.97 B 2.97 B 2.95 B 2.97 B 2.97 B 2.97 B 3.17 B 3.17 B 3.17 B 3.17 B 2.84 B 2.84 B 2.84 B 2.84 B

Cash and Cash Equivalents

210 M 194 M 184 M 188 M 194 M 315 M 373 M 341 M 342 M 298 M 298 M 478 M 579 M - 640 M 698 M 555 M 520 M 546 M 519 M 519 M 519 M 519 M 524 M 524 M 524 M 524 M 500 M 500 M 500 M 500 M 436 M 436 M 436 M 436 M 160 M 160 M 160 M 160 M 202 M 202 M 202 M 202 M 256 M 256 M 256 M 256 M 143 M 143 M 143 M 143 M 367 M 367 M 367 M 367 M 96.4 M 96.4 M 96.4 M 96.4 M

Book Value

2.57 B 2.61 B 2.72 B 2.76 B 2.76 B 2.79 B 2.53 B 2.56 B 2.61 B 2.65 B 2.72 B 2.84 B 2.84 B - 3.02 B 3.01 B 2.88 B 2.81 B 2.87 B 2.89 B 2.89 B 2.89 B 2.89 B 2.79 B 2.79 B 2.79 B 2.79 B 2.71 B 2.71 B 2.71 B 2.71 B 2.91 B 2.91 B 2.91 B 2.91 B 2.44 B 2.44 B 2.44 B 2.44 B 2.54 B 2.54 B 2.54 B 2.54 B 2.95 B 2.97 B 2.97 B 2.97 B 2.95 B 2.97 B 2.97 B 2.97 B 3.17 B 3.17 B 3.17 B 3.17 B 2.84 B 2.84 B 2.84 B 2.84 B

Total Shareholders Equity

1.04 B 1.03 B 1.05 B 1.07 B 1.06 B 1.37 B 1.29 B 1.26 B 1.28 B 1.29 B 1.29 B 959 M 1.22 B 1.22 B 1.22 B 830 M 1.07 B 723 M 700 M 682 M 682 M 682 M 682 M 640 M 640 M 640 M 640 M 635 M 635 M 635 M 635 M 424 M 424 M 424 M 424 M 201 M 201 M 201 M 201 M 269 M 269 M 269 M 269 M 478 M 478 M 478 M 478 M 601 M 601 M 601 M 601 M 734 M 734 M 734 M 734 M 657 M 657 M 657 M 657 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Valhi, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Chemicals

Issuer Price % 24h Market Cap Country
Куйбышевазот Куйбышевазот
KAZT
- - - russiaRussia
Rayonier Advanced Materials Rayonier Advanced Materials
RYAM
$ 8.54 0.47 % $ 570 M usaUSA
Sociedad Química y Minera de Chile S.A. Sociedad Química y Minera de Chile S.A.
SQM
$ 75.66 0.87 % $ 21.6 B chileChile
Westlake Chemical Partners LP Westlake Chemical Partners LP
WLKP
$ 21.74 0.05 % $ 766 M usaUSA
Univar Solutions Univar Solutions
UNVR
- -0.01 % $ 5.99 B usaUSA
Казаньоргсинтез Казаньоргсинтез
KZOS
- - - russiaRussia
Air Products and Chemicals Air Products and Chemicals
APD
$ 297.71 0.57 % $ 66.3 B usaUSA
Ashland Global Holdings Ashland Global Holdings
ASH
$ 72.62 0.1 % $ 3.34 B usaUSA
Braskem S.A. Braskem S.A.
BAK
$ 1.92 1.32 % $ 3.7 B brasilBrasil
Molecular Data Molecular Data
MKD
- 2.5 % $ 2.3 M chinaChina
Ciner Resources LP Ciner Resources LP
CINR
- 0.81 % $ 344 M usaUSA
Роллман Роллман
RLMN
- - - russiaRussia
Celanese Corporation Celanese Corporation
CE
$ 44.53 0.36 % $ 4.88 B usaUSA
DuPont de Nemours DuPont de Nemours
DD
$ 131.32 0.03 % $ 54.8 B usaUSA
Dow Dow
DOW
$ 29.57 0.44 % $ 21 B usaUSA
Eastman Chemical Company Eastman Chemical Company
EMN
$ 70.39 0.59 % $ 8.07 B usaUSA
FutureFuel Corp. FutureFuel Corp.
FF
$ 5.34 1.52 % $ 234 M usaUSA
Huntsman Corporation Huntsman Corporation
HUN
$ 9.8 1.87 % $ 1.69 B usaUSA
AdvanSix AdvanSix
ASIX
$ 16.92 0.46 % $ 455 M usaUSA
LSB Industries LSB Industries
LXU
$ 11.35 0.35 % $ 816 M usaUSA
Methanex Corporation Methanex Corporation
MEOH
$ 60.39 2.84 % $ 4.38 B canadaCanada
Minerals Technologies Minerals Technologies
MTX
$ 70.52 1.28 % $ 2.21 B usaUSA
Нижнекамскнефтехим Нижнекамскнефтехим
NKNC
- - - russiaRussia
Adicet Bio Adicet Bio
ACET
$ 9.73 1.46 % $ 67.1 M usaUSA
Tronox Holdings plc Tronox Holdings plc
TROX
$ 4.8 1.04 % $ 761 M usaUSA